Lisinopril indifferently improves heart rate variability during day and night periods in spontaneously hypertensive rats

Physiological Research

Volumn 62, Issue 3, 2013, Pages 237-245

  Albarwani, S ^a   Al Siyabi, S ^a   Tanira, M O ^b  

^a Department of Physiology ^*  (United States)

^b SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

ACE inhibitor; Circadian rhythm; Heart rate variability; Hypertension; Lisinopril; SHR; Telemetry

Indexed keywords

ANTIHYPERTENSIVE AGENT; LISINOPRIL;

ANIMAL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CIRCADIAN RHYTHM; DRUG EFFECT; HEART RATE; HYPERTENSION; MALE; PATHOPHYSIOLOGY; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT OUTCOME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE; CIRCADIAN RHYTHM; HEART RATE; HYPERTENSION; LISINOPRIL; MALE; RATS; RATS, INBRED SHR; TREATMENT OUTCOME;

EID: 84881519336     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. AKITA M, ISHII K, KUWAHARA M, TSUBONE H: Power spectral analysis of heart rate variability for assessment of diurnal variation of autonomic nervous activity in guinea pigs. Exp Anim 51: 1-7, 2002.
2. AKSELROD S, GORDON D, UBEL FA, SHANNON DC, BERGER AC, COHEN RJ: Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213: 220-222, 1981.
3. BAKRIS G: Are there effects of renin-angiotensin system antagonists beyond blood pressure control. Am J Cardiol 105: 21A-29A, 2010.
4. BANACH T, KOLASIÑSKA-KLOCH W, FURGAŁA A, LASKIEWICZ J: The effect of the year angiotensinconverting enzyme inhibitors (ACE I) intake on circadian heart rate variability in patients with primary hypertension. Folia Med Cracov 42: 129-140, 2001.
5. BASELLI G, CERUTTI S: Identification techniques applied to processing of signals from cardiovascular systems. Med Inform 10: 223-235, 1985.
6. BERTAGNOLLI M, SCHENKEL PC, CAMPOS C, MOSTARDA CT, CASARINI DE, BELLÓ-KLEIN A, IRIGOYEN MC, RIGATTO K: Exercise training reduces sympathetic modulation on cardiovascular system and cardiac oxidative stress in spontaneously hypertensive rats. Am J Hypertens 21: 1188-1193, 2008.
7. BONNEMEIER H, WIEGAND UKH, BRANDES A, KLUGE N, KATUS HA, RICHARDT G, POTRATZ J: Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. J Cardiovasc Electrophysiol 14: 797-799, 2003.
8. DE TOMMASI E, IACOVIELLO M, ROMITO R, CECONI C, GUIDA P, MASSARI F, FRANCOLINI G, BERTOCCHI F, FERRARI R, RIZZON P, PITZALIS MV: Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. Am Heart J 146: E17, 2003.
9. DEL COLLE S, MORELLO F, RABBIA F, MILAN A, NASO D, PUGLISI E, MULATERO P, VEGLIO F: Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 50: 487-496, 2007.
10. DIAS DA SILVA VJ, MONTANO N, SALGADO HC, FAZAN JÚNIOR R: Effects of long-term angiotensin converting enzyme inhibition on cardiovascular variability in aging rats. Auton Neurosci 124: 49-55, 2006.
11. DUPREZ D, DE BUYZERE M, RIETZSCHEL E, RIMBOUT S, KAUFMAN JM, VAN HOECKE MJ, CLEMENT DL: Renin-angiotensin-aldosterone system, RR-interval and blood pressure variability during postural changes after myocardial infarction. Eur Heart J 16: 1050-1056, 1995.
12. EWING DJ, NEILSON JMM, SHAPIRO CM, STEWART JA, REID W: Twenty four hour heart rate variability: effects of posture, sleep and time of day in healthy controls and comparison with bedside tests of autonomic function in diabetic patients. Br Heart J 65: 239-244, 1991.
13. GOLOMBEK DA, ROSENSTEIN RE: Physiology of circadian entrainment. Physiol Rev 90: 1063-1102, 2010.
14. GORDON CJ, PADNOS BK: Prolonged elevation in blood pressure in the unrestrained rat exposed to chlorpyrifos. Toxicology 146: 1-13, 2000.
15. GRASSI G: Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions. J Hypertens 19: 1713-1716, 2001.
16. GRASSI G: Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 54: 690-697, 2009.
17. GÜNTHER A, SALZMANN I, NOWACK S, SCHWAB M, SURBER R, HOYER H, WITTE OW, HOYER D: Heart rate variability-a potential early marker of sub-acute post-stroke infections. Acta Neurol Scand 126: 189-196, 2012.
18. HALLSTROM AP, STEIN PK, SCHNEIDER R, HODGES M, SCHMIDT G, ULM K; CAST INVESTIGATORS: Characteristics of heart beat intervals and prediction of death. Int J Cardiol 100: 37-45, 2005.
19. HOYER D, FRANK B, BARANOWSKI R, ZEBROWSKI JJ, STEIN PK, SCHMIDT H: Autonomic information flow rhythms From heart beat interval to circadian variation. IEEE Eng Med Biol Mag 26: 19-24, 2007.
20. KHAND AU, RANKIN AC, CLELAND JGF, GEMMELL I, CLARK E, MACFARLANE PW: The assessment of autonomic function in chronic atrial fibrillation: description of a non-invasive technique based on circadian rhythm of atrioventricular nodal functional refractory periods. Europace 8: 927-934, 2006.
21. KRAMER K, VOSS HP, GRIMBERGEN JA, MILLS PA, HUETTEMAN D, ZWIERS L, BROCKWAY B: Telemetric monitoring of blood pressure in freely moving mice: a preliminary study. Lab Anim 34: 272-280, 2000.
22. MALLIANI A, PAGANI M, LOMBARDI F, CERUTTI S: Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482-492, 1991.
23. MANCIA G, GRASSI G: Management of essential hypertension. Br Med Bull 94: 189-199, 2010.
24. MANCIA G, LÜSCHER TF, SHEPHERD JT, NOLL G, GRASSI GM: Cardiovascular regulation: basic considerations. In: Cardiovascular Medicine, 3rd Edition. WILLERSON JT, COHN JN, WELLENS JJ, HOMES DR (eds), Springer-Verlag, London, 2007a.
25. MANCIA G, DE BACKER G, DOMINICZAK A, CIFKOVA R, FAGARD R, GERMANO G, GRASSI G, HEAGERTY AM, KJELDSEN SE, LAURENT S, NARKIEWICZ K, RUILOPE L, RYNKIEWICZ A, SCHMIEDER RE, BOUDIER HA, ZANCHETTI A ET AL.: 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25: 1105-1187, 2007b.
26. MENEZES ADA S Jr, MOREIRA HG, DAHER MT: Analysis of heart rate variability in hypertensive patients before and after treatment with angiotensin II-converting enzyme inhibitors. Arq Bras Cardiol 83: 169-172, 2004.
27. MONTANO N, RUSCONE TG, PORTA A, LOMBARDI F, PAGANI M, MALLIANI A: Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt. Circulation 90: 1826-1831, 1994.
28. PAPAIOANNOU VE, VERKERK AO, AMIN AS, DE BAKKER JMT: Intracardiac origin of heart rate variability, pacemaker funny current and their possible association with critical illness. Curr Cardiol Rev 9: 82-96, 2013.
29. PAVITHRAN P, PRAKASH ES, DUTTA TK, MADANMOHAN T: Effect of antihypertensive drug therapy on shortterm heart rate variability in newly diagnosed essential hypertension. Clin Exp Pharmacol Physiol 37: e107-e113, 2010.
30. PORRITT MJ, CHEN M, REWELL SS, DEAN RG, BURRELL LM, HOWELLS DW: ACE inhibition reduces infarction in normotensive but not hypertensive rats: correlation with cortical ACE activity. J Cereb Blood Flow Metab 30: 1520-1526, 2010.
31. PUMPRLA J, HOWORKA K, GROVES D, CHESTER M, NOLAN J: Functional assessment of heart rate variability: physiological basis and practical applications. Int J Cardiol 84: 1-14, 2002.
32. RUBIN MF, BRUNELLI SM, TOWNSEND RR: Variability -the drama of the circulation. J Clin Hypertens 12: 284-287, 2010.
33. RUBINI R, PORTA A, BASELLI G, CERUTTI S, PARO M: Power spectrum analysis of cardiovascular variability monitored by telemetry in conscious unrestrained rats. J Auton Nerv Syst 45: 181-190, 1993.
34. SINGH M, MENSAH GA, BAKRIS G: Pathogenesis and clinical physiology of hypertension. Cardiol Clin 8: 545-559, 2010.
35. SMILDE TD, VAN VELDHUISEN DJ, VAN DEN BERG MP: Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure. Clin Res Cardiol 98: 233-239, 2009.
36. STAUSS HM: Power spectral analysis in mice: What are the appropriate frequency bands. Am J Physiol 292: R902-R903, 2007.
37. STAUSS HM, PERSSON PB: Cardiovascular variability and the autonomic nervous system. J Hypertens 24: 1902-1905, 2006.
38. TASK FORCE OF THE EUROPEAN SOCIETY OF CARDIOLOGY, THE NORTH AMERICAN SOCIETY OF PACING AND ELECTROPHYSIOLOGY: Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043-1065, 1996.
39. THAYER JF, YAMAMOTO SS, BROSSCHOT JF: The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol 141: 122-131, 2010.